ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,755,025 | +20.6% | 258,876 | -46.1% | 1.41% | -9.0% |
| Q2 2023 | $9,748,800 | +132.4% | 480,000 | +108.7% | 1.55% | +63.1% |
| Q1 2023 | $4,195,200 | -51.8% | 230,000 | -45.4% | 0.95% | -54.7% |
| Q4 2022 | $8,708,080 | +369.7% | 421,087 | +475.3% | 2.10% | +521.3% |
| Q2 2022 | $1,854,000 | -60.8% | 73,200 | -51.2% | 0.34% | -45.7% |
| Q1 2022 | $4,734,000 | -6.1% | 150,000 | +20.4% | 0.62% | -17.0% |
| Q4 2021 | $5,044,000 | -25.2% | 124,600 | -49.2% | 0.75% | +37.8% |
| Q2 2021 | $6,742,000 | -2.2% | 245,500 | 0.0% | 0.54% | +134.9% |
| Q1 2021 | $6,894,000 | +1195.9% | 245,500 | +1097.6% | 0.23% | +908.7% |
| Q4 2020 | $532,000 | – | 20,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |